# Truvada

NDC: 61958-0704
Generic name: emtricitabine and tenofovir disoproxil fumarate
Labeler / Manufacturer: Gilead Sciences, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20160310

FDA application: NDA021752

## Active ingredients

- EMTRICITABINE: 133 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-0704"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-0704
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54e82b13-a037-49ed-b4b3-030b37c0ecdd